Program ACTIVE II: Design and Methods for a Multi-Center Community-Based Depression Treatment for Rural and Urban Adults with Type 2 Diabetes

Mary de Groot, Jay Shubrook, Frank Schwartz, W Guyton Hornsby Jr, Yegan Pillay, Chandan Saha, Mary de Groot, Jay Shubrook, Frank Schwartz, W Guyton Hornsby Jr, Yegan Pillay, Chandan Saha

Abstract

Objective: Depression affects one in four adults with type 2 diabetes (T2DM) and is associated with worsened diabetes complications, increased health care costs and early mortality. Rural and low-income urban areas, including the Appalachian region, represent an epicenter of the T2DM epidemic. Program ACTIVE II is a comparative effectiveness treatment trial designed to test whether a combination of cognitive behavioral therapy (CBT) and community-based exercise (EXER) will offer greater improvements in diabetes and depression outcomes compared to individual treatment approaches and usual care (UC). The secondary aims are to assess changes in cardiovascular risk factors across groups and to conduct a cost-effectiveness analysis of predicted incidence of cardiovascular complications across groups.

Methods: The study is a 2-by-2 factorial randomized controlled trial consisting of 4 treatment groups: CBT alone, EXER alone, combination of CBT and EXER, and UC. Adults with T2DM for > 1 year and who meet DSM-IVTR criteria for Major Depressive Disorder (MDD) are eligible to participate at two rural Appalachian sites (southeastern Ohio and West Virginia) and one urban site (Indianapolis). This type II behavioral translation study uses a community-engaged research (CEnR) approach by incorporating community fitness centers and mental health practices as interventionists.

Conclusions: This is the first study to evaluate the comparative effectiveness of combined CBT and exercise in the treatment of depression using community-based intervention delivery. This approach may serve as a national model for expanding depression treatment for patients with T2DM.

Figures

Figure 1
Figure 1
Recruitment Flow Chart Separate randomization lists were generated by the study statistician for use by each study site.

References

    1. Centers for Disease Control and Prevention. Diabetes Report Card 2012. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2012.
    1. American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013;36:1033–46.
    1. Weng C, Coppini DV, Sönksen PH. Geographic and social factors are related to increased morbidity and mortality rates in diabetic patients. Diabet Med. 2001;17:612–617.
    1. Centers for Disease Control and Prevention Centers for Disease Control and Prevention. National Diabetes Surveillance System.
    1. Schwartz F, Ruhil AV, Denham S, Shubrook J, Simpson C. High self-reported prevalence of diabetes mellitus, heart disease and stroke in eleven counties in rural Appalachian Ohio. J Rural Health. 2009;25:225–229.
    1. National Opinion Research Center. An analysis of mental health and substance abuse disparities & access to treatment services in the Appalachian region. 2008.
    1. Arcury TA, Gesler WM, Preisser JS, Sherman J, Spencer J, et al. The effects of geography and spatial behavior on health care utilization among the residents of a rural region. Health Services Research. 2005;40:135–55.
    1. Arcury TA, Preisser JS, Gesler WM, Powers JM. Access to transportation and health care utilization in a rural region. J Rural Health. 2005;21:31–38.
    1. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24:1069–78.
    1. Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, et al. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care. 2000;23:934–42.
    1. de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med. 2001;63:619–30.
    1. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: Impact of depressive symptoms on adherence, function, and costs. Arch Intern Med. 2000;160:3278–3285.
    1. Egede L. Major depression in individuals with chronic medical disorders: prevalence, correlates and association with health resource utilization, lost productivity and functional disability. Gen Hosp Psychiatry. 2007;29:409–16.
    1. Egede LE, Zheng D, Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care. 2002;25:464–470.
    1. Goldney RD, Phillips PJ, Fisher LJ, Wilson DH. Diabetes, depression and quality of life. A population study. Diabetes Care. 2004;27:1066–70.
    1. Jacobson AM, de Groot M, Samson JA. The effects of psychiatric disorders and symptoms on quality of life in patients with type I and type II diabetes mellitus. Qual Life Res. 1997;6:11–20.
    1. Katon WJ, Rutter C, Simon G, Lin EH, Ludman E. The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care. 2005;28:2668–2672.
    1. Zhang X, Norris SL, Gregg EW, Cheng YJ, Beckles G, et al. Depressive symptoms and mortality among persons with and without diabetes. Am J Epidemiol. 2005;161:652–660.
    1. Lustman PJ, Griffith LS, Freedland KE, Kissel SS, Clouse RE. Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med. 1998;129:613–21.
    1. Lustman PJ, Griffith LS, Clouse RE, Freedland KE, Eisen SA, et al. Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med. 1997;59:241–50.
    1. Lustman PJ, Freedland KE, Griffith LS, Clouse RE. Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. Diabetes Care. 2000;23:618–23.
    1. Goodnick PJ, Kumar A, Henry JH, Buki VM, Goldberg RB. Sertraline in coexisting major depression and diabetes mellitus. Psychopharmacol Bull. 1997;33:261–264.
    1. Katon W, von Korff M, Ciechanowski P, Russo J, Lin E, et al. Behavioral and clinical factors associated with depression among individuals with diabetes. Diabetes Care. 2004;27:914–20.
    1. Beltman MW, Voshaar RC, Speckens AE. Cognitive behavioral therapy for depression in people with somatic disease: meta-analyis of randomized controlled trials. Br J Psychiatry. 2010;197:11–19.
    1. Lustman PJ, Freedland KE, Griffith LS, Clouse RE. Predicting response to cognitive behavior therapy of depression in type 2 diabetes. Gen Hosp Psychiatry. 1998;20:302–6.
    1. Blumenthal JA, Babyak MA, Moore KA, Craighead WE, Herman S. Effects of exercise training on older patients with major depression. Arch Intern Med. 1999;159:2349–2356.
    1. Babyak M, Blumenthal JA, Herman S, Khatri P, Doraiswamy M. Exercise treatment for major depression: Maintenance of therapeutic benefit at 10 months. Psychosom Med. 2000;62:633–638.
    1. Craft LL, Landers DM. The effect of exercise on clinical depression and depression resulting from mental illness: a meta-analysis. J Sport Exer Psychol. 1998;20:339–57.
    1. Boulé NG, Haddad E, Kenny GP, Wells GA, Sigal RJ. Effects of exercise on glyemic control and body mass index in type 2 diabetes: A meta-analysis of controlled clinical trials. JAMA. 2001;286:1218–1227.
    1. Kirk A, Mutrie N, MacIntyre P, Fisher M. Effects of a 12-month physical activity counseling intervention on glycemic control and on the status of cardiovascular risk factors in people with type 2 diabetes. Diabetologia. 2004;47:821–32.
    1. Mourier A, Gautier JF, De Kerviler E, Bigard AX, Villette JM. Mobilization of visceral adipose tissue related to the improvement in insulin sensitivity in response to physical training in NIDDM. Diabetes Care. 1997;20:385–91.
    1. Raz I, Hauser E, Bursztyn M. Moderate exercise improves glucose metabolism in uncontrolled elderly patients with non-insulin dependent diabetes mellitus. Isr J Med Sci. 1994;30:766–70.
    1. Di Loreto C, Fanelli C, Lucidi P, Murdolo G, De Cicco A. Validation of a counseling strategy to promote adoption and the maintenance of physical activity by Type 2 diabetes subjects. Diabetes Care. 2003;26:404–8.
    1. Kahn EB, Ramsey LT, Brownson RC, Heath GW, Howze EH. The effectiveness of interventions to increase physical activity. Am J Prev Med. 2002;22:73–107.
    1. Piette JD, Richardson C, Himle J, Duffy S, Torres T. A randomized trial of telephone counseling plus walking for depressed diabetes patients. Med Care. 2011;49:641–8.
    1. de Groot M, Doyle T, Kushnick M, Shubrook J, Merrill J. Can lifestyle interventions do more than reduce diabetes risk? Treating depression in adults with type 2 diabetes with exercise and Cognitive Behavioral Therapy. Curr Diab Rep. 2012;12:157–66.
    1. Spitzer RL, Williams JB, Gibbon M, First MB. The Structured Clinical Interview for DSM-III-R (SCID) - I: History, rationale, and description. Arch Gen Psychiatry. 1992;49:624–629.
    1. Williams JB, Gibbon M, First MB, Spitzer RL, Davies M, et al. The Structured Clinical Interview for DSM-III-R (SCID) - II. Multisite test-retest reliability. Arch Gen Psychiatry. 1992;49:630–636.
    1. Beck AT, Steer RA, Brown GK. BDI-II Beck Depression Inventory Manual. 2. San Antonio, TX: The Psychological Corporation. Harcourt, Brace & Company; 1996.
    1. Lustman PJ, Clouse RE, Griffith LS, Carney RM, Freedland KE. Screening for depression in diabetes using the Beck Depression Inventory. Psychosom Med. 1997;59:24–31.
    1. Ware J, Snow K, Kosinski M, Gandek B. The MOS SF-12 Health Survey: Manual and Interpretation Guide. Vol. 1993. Boston, MA: The Health Institute, New England Medical Center; 1993.
    1. Stewart AL, Greenfield S, Hays RD, Wells K, Rogers WH, et al. Functional status and well-being of patients with chronic conditions. JAMA. 1989;262:907–913.
    1. Godin G, Shephard RJ. A simple method to assess exercise behavior in the community. Can J Appl Sport Sci. 1985;10:141–6.
    1. Diabetes Prevention Program. Diabetes Prevention Program Lifestyle Balance Core Manual. Pittsburgh, PA: University of Pittsburgh; 1996.
    1. Bassett DR, Ainsworth BE, Swartz AM, Strath SJ, O’Brien WL, et al. Validity of four motion sensors in measuring moderate intensity physical activity. Medical Science Sports Exercise. 2000;32:S471–80.
    1. American Thoracic Society. ATS Statement: Guidelines for the Six-Minute Walk Test. Am J Respir Cirt Care Med. 2002;166:111–117.
    1. Albright A, Franz M, Hornsby G, Kriska A, Marrero D, et al. American College of Sports Medicine position stand on exercise and type 2 diabetes. Med Sci Sports Exerc. 2000;32:1345–1360.
    1. Executive Panel. Executive summary of the clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults. Arch Intern Med. 1998;158:1855–67.
    1. Noble BJ, Borg GA, Jacobs I, Ceci R, Kaiser P. A category-ratio perceived exertion scale: relationship to blood and muscle lactates and heart rate. MSSE. 1983;15:523–8.
    1. Beck JS. Cognitive therapy: basics and beyond. New York, NY: Guilford Press; 1995.
    1. Mazzeo RS, Tanaka H. Exercise prescription for the elderly. Sports Med. 2001;31:809–18.
    1. Borg G. Borg’s Perceived Exertion and Pain Scales. Vol. 1998. Champaign, IL: Human Kinetics; 1998.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe